The differential glycosylation and sialylation status of ApoE isoforms serves as a key modulator of ApoE interaction with Aβ, which provides a plausible explanation for the well-established ApoE isoform-dependent Aβ plaques and, ultimately, AD risk. Here, APOE is linked to Alzheimer disease.